Cite
HARVARD Citation
Grupp, K. et al. (2018). FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas. Scientific reports. 8 (1), pp. 1-9. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Grupp, K. et al. (2018). FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas. Scientific reports. 8 (1), pp. 1-9. [Online].